BALLESTRI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 4.876
EU - Europa 1.368
AS - Asia 627
SA - Sud America 10
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 6.895
Nazione #
US - Stati Uniti d'America 4.866
GB - Regno Unito 466
CN - Cina 230
SE - Svezia 225
SG - Singapore 199
IT - Italia 175
DE - Germania 167
UA - Ucraina 84
TR - Turchia 67
FI - Finlandia 62
HK - Hong Kong 58
RU - Federazione Russa 44
BG - Bulgaria 42
FR - Francia 33
LT - Lituania 26
ID - Indonesia 20
VN - Vietnam 12
IN - India 11
CA - Canada 10
CZ - Repubblica Ceca 8
MY - Malesia 8
BE - Belgio 7
BR - Brasile 7
IE - Irlanda 7
NL - Olanda 6
AU - Australia 5
RO - Romania 5
EU - Europa 4
JP - Giappone 3
KR - Corea 3
PH - Filippine 3
AR - Argentina 2
CH - Svizzera 2
IR - Iran 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SI - Slovenia 2
TJ - Tagikistan 2
TW - Taiwan 2
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
ES - Italia 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 6.895
Città #
Fairfield 759
Santa Clara 474
Woodbridge 461
Ashburn 375
Houston 356
Southend 338
Seattle 334
Chandler 312
Wilmington 295
Cambridge 246
Dearborn 192
Ann Arbor 182
Nyköping 165
Singapore 157
Jacksonville 135
Modena 80
New York 67
Hong Kong 58
Beijing 57
Eugene 43
Izmir 43
Princeton 43
San Diego 43
Sofia 42
Helsinki 40
London 23
Jakarta 20
Shanghai 20
Redwood City 17
Des Moines 14
Moscow 13
San Mateo 12
Dong Ket 10
Frankfurt am Main 10
Bremen 9
Hefei 9
Munich 9
North Salt Lake 9
Brno 8
Padova 8
Brussels 7
Dublin 7
Falls Church 7
Nanjing 7
Norwalk 7
Guangzhou 6
Jinan 6
Phoenix 6
Boardman 5
Bologna 5
Dallas 5
Florence 5
Fremont 5
Kunming 5
Rome 5
Augusta 4
Chicago 4
Chiswick 4
Livorno 4
Molise 4
Naples 4
Ottawa 4
São Paulo 4
Toronto 4
Bari 3
Cluj-Napoca 3
Dongguan 3
Falkenstein 3
Hebei 3
Kilburn 3
Leawood 3
Maastricht 3
Monmouth Junction 3
Nanchang 3
San Francisco 3
San Jose 3
Wuxi 3
Acton 2
Auburn Hills 2
Auckland 2
Barletta 2
Betton 2
Canberra 2
Castellana Grotte 2
Chennai 2
Council Bluffs 2
Cremona 2
Faenza 2
Fuzhou 2
Grafing 2
Hangzhou 2
Las Vegas 2
Milan 2
Ningbo 2
Paris 2
Reggio Emilia 2
Romainville 2
Salerno 2
Shenyang 2
Tokyo 2
Totale 5.697
Nome #
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 321
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 258
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 233
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 232
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 212
Nonalcoholic fatty liver disease and aging: epidemiology to management 207
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 204
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 200
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 198
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 198
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 196
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 196
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 194
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 192
A critical appraisal of the use of ultrasound in hepatic steatosis 190
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 184
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 184
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 179
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 173
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 159
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 156
Alcohol and Steatosis: The Japanese Paradox 156
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 155
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 153
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 153
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? 152
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 148
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 146
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 144
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 140
Clinical relevance of liver histopathology and different histological classifications of NASH in adults 137
Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: Chance tetrad or association by necessity? 137
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 131
NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk 130
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 129
Sex Differences in NAFLD: State of the Art and Identification of Research Gaps 127
Hypervascular Retroperitoneal Mass in a Patient with Fever and Leucocytosis - Contrast-Enhanced Ultrasonographic Findings in a Case of Inflammatory Malignant Fibrous Histiocytoma 122
Gli enzimi epatobiliari nella diagnostica clinica delle Epatopatie. 120
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity? 114
Nanoparticles: potential toxins for the organism and the kidney ? 111
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 102
Totale 6.973
Categoria #
all - tutte 29.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.145 0 0 0 0 0 279 290 187 174 66 92 57
2020/20211.266 109 67 103 116 123 129 82 161 63 135 114 64
2021/2022782 34 95 77 31 17 37 48 29 102 75 172 65
2022/2023827 82 126 62 76 87 116 16 79 96 8 34 45
2023/2024457 15 25 42 24 97 61 21 39 10 4 56 63
2024/2025815 48 21 36 121 361 228 0 0 0 0 0 0
Totale 6.973